期刊文献+

甲基莲心碱在K562/A02细胞对STI571敏感性中的作用 被引量:6

Effect of neferine on the chemotherapic sensitivity of STI 571 to K562/A02 cells
下载PDF
导出
摘要 目的:研究甲基莲心碱(Nef)在多药耐药白血病细胞K562/A02对STI571敏感性中的作用,并探讨其逆转耐药的机制。方法:MTT法比较STI571单独或与Nef联合应用对K562/A02细胞的抑制作用;RT-PCR法检测mdr1mRNA转录水平及WesternBlot法检测P-gp表达水平。结果:Nef与STI571联合应用对K562/A02细胞增殖的抑制作用明显增强。单独应用STI571对K562/A02细胞的IC50为3.02μmol/L,加Nef后,IC50为0.689μmol/L,逆转倍数为4.38倍(P<0.05)。STI571与Nef联合应用使mdr1mRNA转录水平下调(45.4±2.5)%(P<0.01),使P-gp的表达下调40.58%(P<0.05)。结论:甲基莲心碱能增强K562/A02细胞对STI571的敏感性,下调其mdr1mRNA的转录和阻断P-gp的表达,从而逆转白血病的多药耐药性。 Objective To explore the effect of neferine on the chemotherapic sensitivity of STI 571 to K562/A02 cells and to reveal its mechanism. Methods MTF method was used to observe the altera- tion of the proliferation of K562/A02 cell line treated with STI 571 alone or combined with neferine. The transcription of mdrl gene was detected by semi-quantitative RT-PCR and the P-gp expression was determined by Western blot after STI 571 alone or combined with neferine treatment. Results The cytotoxic effect of STI 571 ( 1μmol/L) combined with neferine (IC50 = 3.02 μmol/L) on K562/A02 cell line was significantly higher than that of STI 571 alone (IC50 =0. 689 μmol/L). After treating with STI 571 combined with neferine,the synergistic interaction on K562/A02 cells increased 4.38 folds (P 〈 0.05 ) ; the mdrl mRNA expression by semi-quantitative RT-PCR was significantly reduced by (45.4 ±2.5)% (P 〈 0.01 ) ; and the P-gp expression by Western blot was deregulated by 40.58% (P 〈0.05 ). Conclusion Neferine significantly enhances the antineoplastic effect of STI 571 on K562/A02 cells by reducing mdrl mRNA transcription and blocking P-gp expression.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2005年第5期558-561,共4页 Journal of Central South University :Medical Science
基金 湖南省自然科学基金(03JJY5013)
关键词 STI 571 K562/A02 甲基莲心碱 多药耐药 基因 bcr/abl STI 571 K562/A02 neferine muhi-drug resistance gene, bcr/abl
  • 相关文献

参考文献11

  • 1Goldman JM, Melo JV. Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia[J]. N Engl J Med,2001,344(14):1084-1086.
  • 2Thiesing JT, Jones O, Kolibaba KS, et al. Efficacy of STI 571, an abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against bcr-abl- positive cells[J]. Blood,2000,96(9):3195-3199.
  • 3Mahon FX, Deininger MW, Schultheis B, et al. Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI 571: diverse mechanisms of resistance[J]. Blood, 2000,96(3):1070-1079.
  • 4le Coutre P, Tassi E, Varella-Garcia M, et al. Induction of resis-tance to the abelson inhibitor STI 571 in human leukemic cells through gene amplification[J]. Blood, 2000,95(5):1758-1766.
  • 5Gorre ME, Mohammed M, Ellwood K, et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification[J]. Science, 2001, 293(5531):876-880.
  • 6Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myleoid leukemia[J]. N Engl J Med, 2001,344(14):1031-1037.
  • 7林秀梅,谢兆霞,祝焱,祝平安,李薇.急性白血病多药耐药相关蛋白及P糖蛋白表达与临床耐药的关系[J].湖南医科大学学报,2002,27(6):522-524. 被引量:3
  • 8林秀梅,谢兆霞,秦群.甲基莲心碱、红霉素逆转K562/A02细胞多药耐药及其机制的研究[J].中华血液学杂志,2005,26(5):305-307. 被引量:19
  • 9杨纯正,刘淑仪.肿瘤耐药基因表达的临床意义及其逆转研究[J].中国肿瘤,2001,10(3):132-136. 被引量:23
  • 10Yang CZ, Luan FJ, Xiong DS, et al. Multidrug resistance in leukemic cell line K562/A02 induced by doxorubicin[J]. Zhongguo Yao Li Xue Bao, 1995,16(4): 333-337.

二级参考文献19

  • 1贾菊芳,敖明章,胡本容,李勇军,郭毛娣,莫长耕.甲基莲心碱对脂质过氧化和活性氧自由基的作用[J].同济医科大学学报,1994,23(1):62-64. 被引量:17
  • 2谢兆霞,谭达人,谢俊明,秦群,谭桂山,徐平声.“拮新康”的逆转耐药与抗肿瘤作用的研究[J].中国现代医学杂志,1996,6(4):18-19. 被引量:11
  • 3Yang CZ, Luan FJ, Xiong DS, et al. Multidrug resistance in leukemic cell line K562/A02 induced by doxorubicin. Acta Pharmacologica sinica, 1995,16:333-337.
  • 4Muller C, Goubin F, Ferrandis E, et al. Evidence for transcriptional control of human mdrl gene expression by verapamil in multidrug- resistant leukemic cells. Mol Pharmacol, 1995, 47:51-56.
  • 5Terashi K, Oka M, Soda H, et al. Interactions of ofloxacin and erythromycin with the multidrug resistance protein (MRP) in MRP-overexpressing human leukemia cells. Antimicrob Agents Chemother, 2000,44:1697-1700.
  • 6van der Kolk DM, Vellenga E, Muller M, et al. Multidrug resistance protein MRP1, glutathione, and related enzymes. Their importance in acute myeloid leukemia[J]. Adv Exp Med Biol,1999,457:187-198.
  • 7Terashi K, Oka M , Soda H,et al. Interactions of ofloxacin and erythromycin with the multidrug resistance protein (MRP) in MRP-overexpressing human leukemia cells[J].Antimicrob Agents Chemother,2000,44(6):1697-1700.
  • 8Yang CZ,Luan FJ,Xiong DS,et al.Multidrug resistance in leukemic cell line K562/A02 induced by doxorubicin[J]. Zhongguo Yao Li Xue Bao,1995,16(4): 333-337.
  • 9Shen H, Kauvar L, Tew KD .Importance of Glutathionee and associated enzymes in drug response[J]. Oncol Res,1997,9(6-7):295-302.
  • 10Loe DW, Deeley RG, Cole SP. Verapamil stimulates Glutathionee transport by the 190-kDa multidrug resistance protein 1 (MRP1)[J]. J Pharmacol Exp Ther,2000,293(2): 530-538.

共引文献48

同被引文献61

引证文献6

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部